Published in Eksp Klin Farmakol on July 24, 2000
Sigma receptor activation inhibits voltage-gated sodium channels in rat intracardiac ganglion neurons. Int J Physiol Pathophysiol Pharmacol (2009) 0.80
Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (1995) 9.79
Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med (1997) 5.10
Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med (1994) 3.89
A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N Engl J Med (1990) 2.83
A proposal for the classification of sigma binding sites. Trends Pharmacol Sci (1992) 2.65
Comparison of the PREMIER cryptococcal antigen enzyme immunoassay and the latex agglutination assay for detection of cryptococcal antigens. J Clin Microbiol (1991) 2.42
Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Dev (1994) 2.39
Activation of cyclin A-dependent protein kinases during apoptosis. Proc Natl Acad Sci U S A (1994) 2.29
Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin. Clin Infect Dis (2000) 1.89
Naloxone-inaccessible sigma receptor in rat central nervous system. Proc Natl Acad Sci U S A (1983) 1.65
Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. J Clin Microbiol (1997) 1.44
Nalbuphine. Drug Alcohol Depend (1985) 1.30
Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes. Proc Natl Acad Sci U S A (1984) 1.22
Fugu: a compact vertebrate reference genome. FEBS Lett (2000) 1.22
Absolute metabolite quantification by in vivo NMR spectroscopy: II. A multicentre trial of protocols for in vivo localised proton studies of human brain. Magn Reson Imaging (1998) 1.18
(+)-[3H]SKF 10,047, (+)-[3H]ethylketocyclazocine, mu, kappa, delta and phencyclidine binding sites in guinea pig brain membranes. Eur J Pharmacol (1985) 1.16
Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma. J Immunol (2000) 1.12
Opioid agonist and antagonist bivalent ligands. The relationship between spacer length and selectivity at multiple opioid receptors. J Med Chem (1986) 1.11
Stereostructure-activity relationship of opioid agonist and antagonist bivalent ligands. Evidence for bridging between vicinal opioid receptors. J Med Chem (1985) 1.09
Nitrosothiol esters of diclofenac: synthesis and pharmacological characterization as gastrointestinal-sparing prodrugs. J Med Chem (2000) 1.05
Randomised controlled comparison of continuous positive airways pressure, bilevel non-invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emerg Med J (2004) 1.03
Platelet thrombin receptors. Binding of alpha-thrombin is coupled to signal generation by a chymotrypsin-sensitive mechanism. J Biol Chem (1980) 1.01
Peptides as receptor selectivity modulators of opiate pharmacophores. J Med Chem (1986) 1.00
[Significance of cardiac cannabinoid receptors in regulation of cardiac rhythm, myocardial contractility, and electrophysiologic processes in heart]. Izv Akad Nauk Ser Biol (2007) 0.99
In vitro activities of designed antimicrobial peptides against multidrug-resistant cystic fibrosis pathogens. Antimicrob Agents Chemother (1999) 0.99
Dissociation of thrombin from platelets by hirudin. Evidence for receptor processing. J Biol Chem (1979) 0.97
2-Fluoro-4-pyridinylmethyl analogues of linopirdine as orally active acetylcholine release-enhancing agents with good efficacy and duration of action. J Med Chem (1998) 0.94
Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A (1997) 0.94
The role of adenosine 3',5'-monophosphate in dopaminergic inhibition of prolactin release in anterior pituitary cells. Endocrinology (1981) 0.93
Digital subtraction in Gd-DTPA enhanced imaging of the breast. Clin Radiol (1995) 0.92
The hydrolysis of phosphatidylcholine by phospholipase A2 in hamster heart. Can J Biochem Cell Biol (1984) 0.92
Biochemical, behavioral, and electrophysiologic actions of the selective sigma receptor ligand (+)-pentazocine. Neuropsychopharmacology (1988) 0.91
Elimination of false-positive serum reactivity in latex agglutination test for cryptococcal antigen in human immunodeficiency virus-infected population. J Clin Microbiol (1994) 0.90
An oral yohimbine/L-arginine combination (NMI 861) for the treatment of male erectile dysfunction: a pharmacokinetic, pharmacodynamic and interaction study with intravenous nitroglycerine in healthy male subjects. Br J Clin Pharmacol (2005) 0.88
Endogenous cannabinoid anandamide increases heart resistance to arrhythmogenic effects of epinephrine: role of CB(1) and CB(2) receptors. Bull Exp Biol Med (2001) 0.87
Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes. J Pharmacol Exp Ther (1986) 0.87
The purification and characterization of a phospholipase A in hamster heart cytosol for the hydrolysis of phosphatidylcholine. J Biol Chem (1987) 0.86
Light sensitive zinc content of protein fractions from bovine rod outer segments. Biochem Biophys Res Commun (1976) 0.85
Cannabinoid receptor antagonists SR141716 and SR144528 exhibit properties of partial agonists in experiments on isolated perfused rat heart. Bull Exp Biol Med (2005) 0.85
Endogenous cannabinoids improve myocardial resistance to arrhythmogenic effects of coronary occlusion and reperfusion: a possible mechanism. Bull Exp Biol Med (2002) 0.85
Magnetic resonance imaging of hemochromatosis arthropathy. Skeletal Radiol (1994) 0.85
A multifunctional cyclic nucleotide- and Ca2+-independent protein kinase from rabbit skeletal muscle. Biochem Biophys Res Commun (1982) 0.84
Electrophysiological effects of selective sigma-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons. Neuropsychopharmacology (1989) 0.83
Activation of type II cannabinoid receptors improves myocardial tolerance to arrhythmogenic effects of coronary occlusion and reperfusion. Bull Exp Biol Med (2001) 0.83
Role of cannabinoid receptors in the regulation of cardiac contractility during ischemia/reperfusion. Bull Exp Biol Med (2006) 0.83
Aerosolized amiloride as treatment of cystic fibrosis lung disease: a pilot study. Adv Exp Med Biol (1991) 0.83
Studies on the role of K+, Cl- and Na+ ion permeabilities in the acetylcholine release enhancing effects of linopirdine (DuP 996) in rat cortical slices. J Pharmacol Exp Ther (1994) 0.82
Selective reversible and irreversible ligands for the kappa opioid receptor. J Med Chem (1992) 0.82
Activation of kappa-opioid receptor as a method for prevention of ischemic and reperfusion arrhythmias: role of protein kinase C and K(ATP) channels. Bull Exp Biol Med (2007) 0.82
[Anandamide and R-(+)-methanandamide prevent development of ischemic and reperfusion arrhythmia in rats by stimulation of CB2-receptors]. Eksp Klin Farmakol (2002) 0.82
High-throughput genomic and proteomic analysis using microarray technology. Clin Chem (2001) 0.82
Synthesis and opioid activity of 7-oxygenated 2,3,4,4a,5,6,7,7a-octahydro-1H-benzofuro[3,2-e]isoquinolin-9-ols. J Med Chem (1994) 0.81
[Cardioprotective effect of remote ischemic preconditioning]. Angiol Sosud Khir (2009) 0.80
Differential interaction of rabbit skeletal muscle phosphorylase kinase isozymes with calmodulin. J Biol Chem (1980) 0.80
[Cardioprotective and antiarrhythmic properties of Rhodiolae roseae preparations]. Eksp Klin Farmakol (2007) 0.80
[Neuroprotective effect of ischemic postconditioning and remote preconditioning. Prospective of clinical use]. Angiol Sosud Khir (2012) 0.80
[Reactive oxygen species are triggers and mediators of an increase in cardiac tolerance to impact of ischemia-reperfusion]. Ross Fiziol Zh Im I M Sechenova (2015) 0.79
Metabolic alterations in rat myocardium in experimental acute atrial fibrillation. Bull Exp Biol Med (2005) 0.79
Suppression of proliferation of human coronary artery smooth muscle cells by the nitric oxide donor, S-nitrosoglutathione, is cGMP-independent. Mol Cell Biol Res Commun (2000) 0.79
Selective cannabinoid receptor agonist HU-210 decreases pump function of isolated perfused heart: role of cAMP and cGMP. Bull Exp Biol Med (2004) 0.79
Ligands for opioid and sigma-receptors improve cardiac electrical stability in rat models of post-infarction cardiosclerosis and stress. Life Sci (1999) 0.79
Selective sigma receptor agonist and antagonist affect dopamine neuronal activity. Eur J Pharmacol (1989) 0.78
[The cardioprotective and antiadrenergic activity of an extract of Rhodiola rosea in stress]. Eksp Klin Farmakol (1995) 0.78
Role of Intracellular Calcium and Cyclic Nucleotides in Realization of Cardioprotective Effects of δ(1)- and κ(1)-Opioid Receptor Agonists. Bull Exp Biol Med (2009) 0.78
Bivalent opioid peptide analogues with reduced distances between pharmacophores. Life Sci (1987) 0.78
[Increase of the heart arrhythmogenic resistance and decrease of the myocardial necrosis zone during activation of cannabinoid receptors]. Ross Fiziol Zh Im I M Sechenova (2002) 0.78
[3H]beta-funaltrexamine binds covalently to brain opioid receptors. Eur J Pharmacol (1985) 0.78
Opioid peptide deltorphin II simulates the cardioprotective effect of ischemic preconditioning: role of δ₂-opioid receptors, protein kinase C, and K(ATP) channels. Bull Exp Biol Med (2010) 0.78
Activation of cannabinoid receptors decreases the area of ischemic myocardial necrosis. Bull Exp Biol Med (2002) 0.78
Cardioprotective effect of kappa1-opioid receptor activation and role of cAMP in its realization. Bull Exp Biol Med (2007) 0.78
3-Substituted, 3-(4-pyridinylmethyl)-1,3-dihydro-1-phenyl-2H-indol-2-ones as acetylcholine release enhancers: synthesis and SAR. J Med Chem (1993) 0.78
Binding of thrombin to human platelet plasma membranes. Biochim Biophys Acta (1978) 0.78
Use of the Suzuki reaction for the synthesis of aryl-substituted heterocycles as corticotropin-releasing hormone (CRH) antagonists. Bioorg Med Chem Lett (1999) 0.77
Activation of peripheral delta opioid receptors eliminates cardiac electrical instability in a rat model of post-infarction cardiosclerosis via mitochondrial ATP-dependent K+ channels. Life Sci (2003) 0.77
[3H]linopirdine (DuP 996) labels a novel binding site in rat brain involved in the enhancement of stimulus-induced neurotransmitter release: autoradiographic localization studies. Brain Res (1992) 0.77
[Antiarrhythmic effect of the antiopioid peptide nociceptin and its effect on fast Na+-channels in cardiomyocytes]. Biull Eksp Biol Med (1998) 0.77
[Hypoxic preconditioning of stem cells as a new approach to increase the efficacy of cell therapy for myocardial infarction]. Vestn Ross Akad Med Nauk (2013) 0.77
[The participation of the mu-, delta- and kappa-opioid receptors in the realization of the anti-arrhythmia effect of Rhodiola rosea]. Eksp Klin Farmakol (1997) 0.77
Opioid receptors and heart resistance to arrhythmogenic factors. Bull Exp Biol Med (2004) 0.77
[The role of sarcolemmal and mitochondrial K(ATP)-channels in realization of the cardioprotection and antiarrhythmic effect of different regimens of hypobaric adaptation]. Ross Fiziol Zh Im I M Sechenova (2009) 0.77
[Delta-opioid receptor agonists prevent the irreversible damage of cardiomyocytes in ischemized-reperfused isolated rat heart]. Eksp Klin Farmakol (2005) 0.77
[Do endogenous ligands of peripheral mu- and delta-opiate receptors mediate anti-arrhythmic and cardioprotective effects of Rhodiola rosea extract?]. Biull Eksp Biol Med (1997) 0.77
Effect of stress adaptation on cyclic nucleotide content in myocardial tissue during acute ischemia/reperfusion. Bull Exp Biol Med (2008) 0.77
Dopaminergic inhibition of ionophore A23187-stimulated release of prolactin from rat anterior pituitary cells. J Biol Chem (1980) 0.77
[Role of kappa1 opioid receptors and cAMP in regulation of cardiac tolerance to ischemia and reperfusion]. Izv Akad Nauk Ser Biol (2008) 0.77
Functional state of myocardial mitochondria in ischemia reperfusion of the heart in rats adapted to hypoxia. Bull Exp Biol Med (2014) 0.77
[Role of delta opioid receptors and their ligands in the development of adaptive heart protection against arrhythmogenesis]. Ross Fiziol Zh Im I M Sechenova (2001) 0.77
[Problem of end-effector of ischemic postconditioning of the heart]. Ross Fiziol Zh Im I M Sechenova (2013) 0.77
Role of cyclic nucleotides and NO synthase in mechanisms of cardioprotective effects of cannabinoid HU-210. Bull Exp Biol Med (2014) 0.76
Discriminative stimulus properties of (+)-N-allylnormetazocine in the rat: correlations with (+)-N-allylnormetazocine and phencyclidine receptor binding. Psychopharmacology (Berl) (1987) 0.76
[Ischemic postconditioning of the heart. Receptor mechanisms and possibility of clinical use]. Kardiologiia (2010) 0.76
[Role of heat shock proteins, aldose reductase, Bcl-2 protein and microRNA in the mechanism of delayed preconditioning of heart]. Ross Fiziol Zh Im I M Sechenova (2010) 0.76
Antiarrhythmic activity of phytoadaptogens in short-term ischemia-reperfusion of the heart and postinfarction cardiosclerosis. Bull Exp Biol Med (2009) 0.76